Q5100 – Injection, ustekinumab-kfce (yesintek), biosimilar, 1 mg

Long description

Injection, ustekinumab-kfce (yesintek), biosimilar, 1 mg

Short description

Inj ustekinumab-kfce, 1 mg

Pricing indicator

51 Drugs

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

O1E Other drugs

ASC

Approved for ambulatory surgical centers

Added

July 1, 2025

Last change

July 1, 2025 – No change

Nearby Q codes

• Q5005 – Hospice care provided in inpatient hospital
• Q5006 – Hospice care provided in inpatient hospice facility
• Q5007 – Hospice care provided in long term care facility
• Q5008 – Hospice care provided in inpatient psychiatric facility
• Q5009 – Hospice or home health care provided in place not otherwise specified (nos)
• Q5010 – Hospice home care provided in a hospice facility
• Q5098 – Injection, ustekinumab-srlf (imuldosa), biosimilar, 1 mg
• Q5099 – Injection, ustekinumab-stba (steqeyma), biosimilar, 1 mg
• Q5101 – Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram
• Q5102 – Injection, infliximab, biosimilar, 10 mg
• Q5103 – Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg
• Q5104 – Injection, infliximab-abda, biosimilar, (renflexis), 10 mg
• Q5105 – Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units
• Q5106 – Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units
• Q5107 – Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg
• Q5108 – Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg